LeafNLP Demos
Back to explore

Report #2871127

Received Nov 6, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
KY
Recovered
Unknown
Vaccinated
Oct 24, 2025
Onset
Oct 24, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK3SB3G—

Symptoms (1)

Expired product administered

Symptom narrative

Expire dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 3SB3G, expiry date 16-OCT-2025) for prophylaxis. On 24-OCT-2025, the patient received Arexvy. On 24-OCT-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expire dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 24-OCT-2025 The pharmacist reported they administer an expire dose of Arexvy vaccine. The vaccine administration facility was the same as primary reporter.